![Zachary Brecheisen](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3248621/8730d102-8c9b-4917-82f2-4b701c4f706e/profile.png)
Zachary Brecheisen
USA Guide 2024
Band 2 : Corporate/M&A & Private Equity
Email address
[email protected]Contact number
1.412.394.7284Share profile
Band 2
About
Provided by Zachary Brecheisen
Career
Zach Brecheisen is a corporate lawyer focusing his practice on mergers and acquisitions and other strategic transactions. He counsels clients on a variety of corporate governance matters, including activist investor campaigns. Zach places a premium on efficiency in providing clients with forthright and practical legal advice in high-pressure situations. He taps his background as an engineer to manage cross-functional teams on complex issues, while driving transactions forward and achieving client goals.
Zach advises clients across a broad range of industries. Recently he represented Evoqua (NYSE: AQUA) in its $7.5 billion sale to Xylem; Cibus Global (Nasdaq: CBUS) in its reverse merger with Calyxt; Misonix (Nasdaq: MSON) in its $520 million sale to Bioventus; and Ansys (Nasdaq: ANSS) in numerous acquisitions (including its $700 million acquisition of AGI). Zach advised midwestern stalwarts like U. S. Steel (NYSE: X) in its sale of Transtar for $640 million and its option agreement with Stelco for a potential $2.4 billion joint venture.
Zach was previously a project engineer advising electric utilities on transmission and distribution system planning.
Zach co-chairs the Firm’s LGBTQ+ Affinity Group and has been honored by Penn State University for his contributions to the law school and DEI in the profession.
Discover other Lawyers at
Jones Day
California
![David C Kiernan](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3150513/ca77f10a-d5b7-4037-9af7-150483ce94b5/profile.png)
![Margaret A Ward](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3150423/b16b80f2-1f8e-4665-842f-a3e79f88959d/profile.png)
![Daniel D McMillan](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3087068/e17da0d4-6768-413a-9d5f-8fbd0974bc23/profile.png)
![James R Dutro](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3097845/870469c3-0208-415e-b4f3-9dca0464a3d3/profile.png)
![Catherine Ehrgott](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3097841/c1c200cf-5e78-4038-a2d3-1b2e9a8ff0c6/profile.png)
![Claire Castles](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3181116/599c46ce-6b5d-43ca-9dd8-9a5060d0ee7a/profile.png)
![Tyrone R Childress](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3168985/29c1f7f1-26bc-4acf-a3cc-2ccd4528a779/profile.png)
![Richard DeNatale](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3081077/3cb5782b-f28c-4979-92ef-ccadf512ec31/profile.png)
![Brian D. McDonald](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3081113/b5e23ef7-c937-44f7-8927-133992400d85/profile.png)
![Anthony M. Insogna](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3186849/32a2df36-8f23-4806-9e7e-79a1dbd77844/profile.png)
![Tamera M Weisser](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3292259/e1bd779f-960a-4210-afde-e60eec8e3c3c/profile.png)